Clinical Trial Supply and Logistics Market Growth, Share Analysis and Outlook 2034
Clinical Trial Supply and Logistics Market Growth, Size, Trends Analysis - By Service, By Phase, By Therapeutic Area, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: HLCA25322 | Pages: 1 - 221 | Formats*: |
| Category : Healthcare | |||
Clinical Trial Supply and Logistics Market Introduction and Overview
According to SPER Market Research, the Global Clinical Trial Supply and Logistics Market is estimated to reach USD 9.75 billion by 2034 with a CAGR of 8.21%.
The report includes an in-depth analysis of the Global Clinical Trial Supply and Logistics Market, including market size and trends, product mix, Applications, and supplier analysis. The global market for clinical trial supply and logistics was valued at approximately USD 4.43 billion in 2024, with a projected compound annual growth rate (CAGR) of 8.21% from 2025 to 2034. The increasing adoption of precision medicine, biologics, and decentralized trials has notably heightened the complexity of supply chains. Advanced therapies necessitate strict temperature controls, tailored packaging, and real-time tracking to maintain product integrity. This demand has led to a rise in the need for specialized logistics providers adept at managing intricate supply chains, thus promoting market expansion.
By Service Insights
The logistics and distribution segment was the largest in 2024, driven by growing trial complexity, globalization, and strict regulatory requirements. There is rising demand for temperature-controlled transportation, just-in-time deliveries, and real-time shipment tracking, leading to investments in cold chain logistics. The global expansion of clinical trials requires regional distribution hubs to improve supply chain efficiency. Compliance with regulations like Good Distribution Practices (GDP) heightens the need for specialized logistics providers. The shift to direct-to-patient models and decentralized trials increases demand for flexible distribution solutions.
By Phase Insights
In the clinical trial supply and logistics market, the phase III segment held the largest share in 2024, due to increased clinical trial activities, extensive patient enrollment, complex protocols, and regulatory costs. Investments in logistics are driven by the demand for temperature-controlled storage and global distribution networks. The phase II segment is anticipated to grow, influenced by increased trial volumes and demands for temperature-sensitive biologics.
By Therapeutic Area Insights
In 2024, the cardiovascular diseases segment had the largest market share due to the rising number of heart disease cases and the focus on new medicines to treat these conditions. Companies are implementing strategies to lower heart attack and stroke rates. The oncology segment is expected to grow significantly, driven by the demand for personalized cancer therapies, biologics, and cell & gene treatments, which require careful logistics and regulatory compliance.
By End User Insights
In terms of end user, the pharmaceutical segment held the largest share in 2024, fueled by increased R&D investments and complex trial designs. The growing globalization of clinical trials and the need for advanced logistics solutions support this growth. The biologicals segment is anticipated to grow rapidly, driven by the demand for biologics like vaccines and increased investment in product development.
Regional Insights
North America led the market, holding the largest revenue share in 2024. This region is responsible for the highest number of clinical trials conducted globally, serving as a significant catalyst for the growth of the clinical trial supply and logistics market. A substantial increase in investments in clinical trials, along with a rise in the number of participants in the clinical trial supply and logistics sector, is anticipated to further drive growth.
The Asia-Pacific region is projected to experience robust growth during the forecast period, attributed to an upsurge in clinical trial activities, reduced operational costs, and an expanding pharmaceutical industry. Nations such as China, India, and Japan are pivotal hubs, drawing global sponsors due to their diverse patient populations and regulatory advancements.
Market Competitive Landscape
The Global Clinical Trial Supplies and Logistics industry is marked by the presence of leading companies such as Parexel International, Catalent, Inc., Thermo Fisher Scientific, Inc., and DHL International GmbH, which compete in terms of service offerings, geographical reach, technological advancements, and partnerships. Mergers and acquisitions are crucial strategies employed by these companies to broaden their service offerings and geographical footprint. Establishing partnerships with pharmaceutical firms and contract research organizations (CROs) further enhances their market presence.
Recent Developments:
- In March 2025, DHL Group revealed its acquisition of Cryoport, Inc.’s CRYOPDP, aimed at bolstering its supply chain services for the global life sciences and healthcare industry. CRYOPDP specializes in courier services for clinical trials, biopharmaceuticals, and cell and gene therapy.
- In January 2025, Thermo Fisher Scientific formed a partnership with Pfizer to improve supply chain transparency through the integration of blockchain technology. This collaboration is designed to enhance drug traceability, reduce counterfeiting risks, and optimize the real-time monitoring of investigational drugs during clinical trials. By utilizing blockchain technology, both organizations aim to strengthen data security, ensure regulatory compliance, and streamline logistics operations across global trial sites.
- In November 2024, FedEx announced the expansion of its Korea Life Science Center located in Gimpo, South Korea, to enhance healthcare logistics in the area. The facility features five distinct temperature-controlled zones, accommodating temperatures ranging from -150 °C to 25 °C. Additionally, the facility guarantees compliance with pharmaceutical cold chain regulations.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Service, By Phase, By Therapeutic Area, By End User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, Middle East & Africa |
| Companies Covered | Thermo Fisher Scientific Inc, UPS Healthcare, Piramal Pharma Solutions, DHL, Parexel International, Almac Group, Movianto, UDG Healthcare, FedEx, Catalent, Inc. |
Key Topics Covered in the Report
- Global Clinical Trial Supply and Logistics Market Size (FY’2021-FY’2034)
- Overview of Global Clinical Trial Supply and Logistics Market
- Segmentation of Global Clinical Trial Supply and Logistics Market By Service (Logistics & Distribution, Storage & Retention, Packaging, Labeling, and Blinding, Manufacturing, Comparator Sourcing, Other Services)
- Segmentation of Global Clinical Trial Supply and Logistics Market By Phase (Phase I, Phase II, Phase III, Phase IV)
- Segmentation of Global Clinical Trial Supply and Logistics Market By Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS and Mental Disorders, Others)
- Segmentation of Global Clinical Trial Supply and Logistics Market By End User (Pharmaceuticals, Biologicals, Medical Device)
- Statistical Snap of Global Clinical Trial Supply and Logistics Market
- Expansion Analysis of Global Clinical Trial Supply and Logistics Market
- Problems and Obstacles in Global Clinical Trial Supply and Logistics Market
- Competitive Landscape in the Global Clinical Trial Supply and Logistics Market
- Details on Current Investment in Global Clinical Trial Supply and Logistics Market
- Competitive Analysis of Global Clinical Trial Supply and Logistics Market
- Prominent Players in the Global Clinical Trial Supply and Logistics Market
- SWOT Analysis of Global Clinical Trial Supply and Logistics Market
- Global Clinical Trial Supply and Logistics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3 .Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Clinical Trial Supply and Logistics Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Clinical Trial Supply and Logistics Market
7. Global Clinical Trial Supply and Logistics Market, By Service (USD Million) 2021-2034
- 7.1. Logistics & Distribution
- 7.2. Storage & Retention
- 7.3. Packaging, Labeling, and Blinding
- 7.4. Manufacturing
- 7.5. Comparator Sourcing
- 7.6. Other Services
8. Global Clinical Trial Supply and Logistics Market, By Phase (USD Million) 2021-2034
- 8.1. Phase I
- 8.2. Phase II
- 8.3. Phase III
- 8.4. Phase IV
9. Global Clinical Trial Supply and Logistics Market, By Therapeutic Area (USD Million) 2021-2034
- 9.1. Oncology
- 9.2. Cardiovascular Diseases
- 9.3. Respiratory Diseases
- 9.4. CNS and Mental Disorders
- 9.5. Others
10. Global Clinical Trial Supply and Logistics Market, By End User (USD Million) 2021-2034
- 10.1. Pharmaceuticals
- 10.2. Biologicals
- 10.3. Medical Device
11. Global Clinical Trial Supply and Logistics Market, (USD Million) 2021-2034
- 11.1. Global Clinical Trial Supply and Logistics Market Size and Market Share
12. Global Clinical Trial Supply and Logistics Market, By Region, (USD Million) 2021-2034
- 12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
- 12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
- 12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
- 12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
- 12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America
13. Company Profile
- 13.1. Thermo Fisher Scientific Inc
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. UPS Healthcare
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Piramal Pharma Solutions
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. DHL
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Parexel International
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3.Product summary
- 13.5.4. Recent developments
- 13.6. Almac Group
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Movianto
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. UDG Healthcare
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. FedEx
- 13.10.1. Company details
- 13.10.2. Financial outlook
- 13.10.3 Product summary
- 13.10.4. Recent developments
- 13.10.Catalent, Inc
- 13.11.1. Company details
- 13.11.2. Financial outlook
- 13.11.3. Product summary
- 13.11.4. Recent developments
- 13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Clinical Trial Supply and Logistics Market is projected to reach USD 9.75 billion by 2034, growing at a CAGR of 8.21% during the forecast period.
Clinical Trial Supply and Logistics Market grew in Market size from 2025. The Market is expected to reach USD 9.75 billion by 2034, at a CAGR of 8.21% during the forecast period.
Clinical Trial Supply and Logistics Market CAGR of 8.21% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Clinical Trial Supply and Logistics Market size is USD 9.75 billion from 2025 to 2034.
Clinical Trial Supply and Logistics Market is covered By Service, By Phase, By Therapeutic Area, By End User
North America is anticipated to have the highest Market share in the Clinical Trial Supply and Logistics Market.
Thermo Fisher Scientific Inc, UPS Healthcare, Piramal Pharma Solutions, DHL, Parexel International, Almac Group, Movianto, UDG Healthcare, FedEx, Catalent, Inc.
The report includes an in-depth analysis of the Global Clinical Trial Supply and Logistics Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
